Growing at a rate of knots from the Cambridge Biomedical Campus, AstraZeneca hoisted its market cap to £183.58 billion and ...
Paragraf, which is pioneering the mass production of graphene-based electronics with standard semiconductor processes, has ...
A transatlantic Cambridge2Cambridge alliance between Qureight in the UK and Avalyn Pharma Inc in Massachusetts – is seeking ...
As 2025 kicks off there’s lots of activity in the world of IP – particularly in the Biotech and Pharma sectors, writes Marc ...
Cambridge UK superchip architect Arm saw its stock on the Nasdaq market in the US climb almost seven per cent and $11 to $173 ...